lyubomyr L.
- Country
- Germany
- Department
- Klinik und Poliklinik für Augenheilkunde
Research Overview
- Evaluation of Ranibizumab with or without Early Targeted Peripheral Laser Photocoagulation in Macular Edema Secondary to Central Retinal Vein Occlusion
- Efficacy and Safety Evaluation of Dexamethasone (OCS-01) Eye Drops in Diabetic Macular Edema: A Phase 3 Randomized, Double-Masked, Multicenter Study
- Evaluation of Safety, Tolerability, and Pharmacokinetics of Single Ascending Doses of STK-002 in Autosomal Dominant Optic Atrophy Patients
Data & Insights
Has run more than one trial at 16 of 94 partner sites.
Specializations
Retinal Vascular Disorders
Specializes in treating macular edema conditions, particularly those associated with central retinal vein occlusion. The investigator explores innovative therapeutic approaches combining ranibizumab injections with peripheral laser photocoagulation.
- Central Retinal Vein Occlusion Management
- Advanced Macular Edema Treatment
- Combined Therapy Approaches
Degenerative Eye Conditions
Focuses on advanced treatments for geographic atrophy and age-related macular degeneration. The investigator studies innovative gene therapy approaches and conducts research on autosomal dominant optic atrophy.
- Macular Degeneration Interventions
- Genetic Eye Disease Management
- Novel Therapeutic Solutions
Rare Ophthalmological Conditions
Specializes in treating rare genetic eye disorders including Leber congenital amaurosis and thyroid eye disease. The investigator evaluates novel therapeutic compounds and investigational treatments for these challenging conditions.
- Genetic Ocular Disorders
- Thyroid-Related Eye Conditions
- Innovative Treatment Protocols
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.